41972-62-7 Usage
Description
Benzo[d][1,2,3]thiadiazol-6-amine, a heterocyclic organic compound with the molecular formula C7H5NS, features a benzene ring fused to a 1,2,3-thiadiazole ring. benzo[d][1,2,3]thiadiazol-6-aMine holds promise in medicinal chemistry, serving as a versatile building block for the synthesis of biologically active molecules. Its potential as a fluorescent probe in biological imaging and its demonstrated anticancer and antiviral activities in research studies make it a significant candidate for further exploration in drug development.
Uses
Used in Medicinal Chemistry:
Benzo[d][1,2,3]thiadiazol-6-amine is utilized as a building block for the synthesis of various biologically active compounds, contributing to the development of new pharmaceuticals with potential therapeutic applications.
Used in Biological Imaging:
benzo[d][1,2,3]thiadiazol-6-aMine serves as a fluorescent probe, enabling the visualization and study of biological processes through fluorescence imaging techniques, which can be instrumental in research and diagnostics.
Used in Anticancer Research:
Benzo[d][1,2,3]thiadiazol-6-amine and its derivatives have shown potential anticancer activities, making them valuable for further research and development of novel cancer therapeutics.
Used in Antiviral Research:
benzo[d][1,2,3]thiadiazol-6-aMine has also demonstrated antiviral properties, indicating its potential use in the development of antiviral drugs to combat viral infections.
Check Digit Verification of cas no
The CAS Registry Mumber 41972-62-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,1,9,7 and 2 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 41972-62:
(7*4)+(6*1)+(5*9)+(4*7)+(3*2)+(2*6)+(1*2)=127
127 % 10 = 7
So 41972-62-7 is a valid CAS Registry Number.
41972-62-7Relevant articles and documents
Histone lysine methyltransferase NSD2 inhibiting small-molecule compound and application thereof
-
Paragraph 0084-0089, (2019/05/22)
The invention belongs to the field of chemical medicine and particularly relates to a histone lysine methyltransferase NSD2 inhibiting small-molecule compound. A general formula of the small-moleculecompound is as shown in the specification. According to
SELECTIVE ANDROGEN RECEPTOR MODULATORS
-
Page/Page column 44-45, (2012/04/23)
This invention provides compounds of formula I, pharmaceutical compositions comprising a compound of formula I and a pharmaceutically acceptable excipient, methods of modulating the androgen receptor, methods of treating diseases beneficially treated by an androgen receptor modulator (e.g., sarcopenia, prostate cancer, contraception, type 2 diabetes related disorders or diseases, anemia, depression, and renal disease) and processes for making compounds and intermediates useful in the preparation of same.
